 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

JUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Dawson James Securities, Inc. ( Dawson ), a full-service investment bank focused on emerging growth companies, today announces...

Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference

Kintara Therapeutics Announces Fiscal 2023 Year Financial Results and Provides Corporate Update Kintara Therapeutics Announces Fiscal 2023 Year Financial Results and Provides Corporate Update PR...

Kintara Therapeutics Announces Fiscal 2023 Year Financial Results and Provides Corporate Update

Kintara Therapeutics to Present at the 2023 European Association for Neuro-Oncology Annual Meeting Kintara Therapeutics to Present at the 2023 European Association for Neuro-Oncology Annual Meeting...

Kintara Therapeutics to Present at the 2023 European Association for Neuro-Oncology Annual Meeting

Kintara Therapeutics to Host Virtual KOL Event on VAL-083, A Potential First-in-Class Small Molecule Chemotherapeutic for Glioblastoma, on August 21, 2023 Kintara Therapeutics to Host Virtual KOL Event on VAL-083, A Potential First-in-Class Small Molecule Chemotherapeutic for Glioblastoma, on...

Kintara Therapeutics to Host Virtual KOL Event on VAL-083, A Potential First-in-Class Small Molecule Chemotherapeutic for Glioblastoma, on August 21, 2023

Kintara Therapeutics to Present at the Emerging Growth Conference Kintara Therapeutics to Present at the Emerging Growth Conference PR Newswire SAN DIEGO, Aug. 9, 2023 SAN DIEGO, Aug. 9, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc.(Nasdaq: KTRA) ('Kintara' or the 'Company&quot...

Kintara Therapeutics to Present at the Emerging Growth Conference

MIAMI, Aug. 08, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 60th Emerging Growth Conference on August 9, 10, 2023. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management ...

Presenting on the Emerging Growth Conference on August 9 & 10 Register Now

Kintara Therapeutics to Participate in the Fifth Annual Glioblastoma Awareness Day in Washington, D.C. Kintara Therapeutics to Participate in the Fifth Annual Glioblastoma Awareness Day in...

Kintara Therapeutics to Participate in the Fifth Annual Glioblastoma Awareness Day in Washington, D.C.

Maxim Group upgraded shares of Kintara Therapeutics (NASDAQ:KTRA Free Report) from a hold rating to a buy rating in a research report report published on Friday morning, MarketBeat Ratings reports. Kintara Therapeutics Stock Performance Shares of Kintara Therapeutics stock opened at $4.64 on Friday...

Kintara Therapeutics (NASDAQ:KTRA) Lifted to "Buy" at Maxim Group

Kintara Therapeutics Awarded $2.0 Million National Institutes of Health SBIR Grant to Support the Clinical Development of REM-001 Kintara Therapeutics Awarded $2.0 Million National Institutes of Health SBIR Grant to Support the Clinical Development of REM-001 PR Newswire SAN DIEGO, June 28, 2023...

Kintara Therapeutics Awarded $2.0 Million National Institutes of Health SBIR Grant to Support the Clinical Development of REM-001

Kintara Therapeutics to Participate in the Maxim Group Virtual Healthcare Conference Kintara Therapeutics to Participate in the Maxim Group Virtual Healthcare Conference PR Newswire SAN DIEGO, June 16, 2023 SAN DIEGO, June 16, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc.(Nasdaq: KTRA...

Kintara Therapeutics to Participate in the Maxim Group Virtual Healthcare Conference

Kintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. Its product pipeline includes VAL-083 and REM-001. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.

Watchers	11,970
52-Wk Low	$2.70
52-Wk High	$15.50

Market Cap	$7.38M
Volume (M)	13,227.00
52-Wk High	$15.50
52-Wk Low	$2.70

KTRA Kintara Therapeutics Inc

About

Feed

News

Fundamentals